Newsfiscal.ai
PMGC Holdings Announces Completion of Preclinical Study for EL-32 Probiotic Candidate
· Published
Article summary
PMGC Holdings Inc. has completed a preclinical study for its engineered probiotic candidate, EL-32, developed by its subsidiary NorthStrive Biosciences Inc.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…